The protein chemistry expertise and personalized approach to advance your large molecule.
The success of your biotherapeutic drug development depends on having the right analytical and bioanalytical CRO partner. Anything less could mean delayed or inaccurate results.
When you need large molecule and protein chemistry expertise to accelerate your drug development, go with the pro — Prolytix.
Scientist Spotlight
John Maddalena, Ph.D.
Specializing in the development and validation of analytical test methods, Dr. Maddalena has been integral to Prolytix’s advances in protein therapeutics.
Explore Our Biotherapeutic Development Resources
Prolytix stands out as a service provider of choice due to an impressive depth of blood and protein knowledge and a higher touch service model versus larger players.
Senior program manager, biotech company focused on immune deficiency disorders
The scientific knowledge and rigor Prolytix brought to the table was excellent, and turnaround time was fantastic compared to the large, global CROs. Prolytix clearly understood the scope of our request, their written reports were clear and exceeded our expectations for GMP scientific reports.
CEO, biotech company focused on development of immuno-oncology and infectious diseases therapeutics
The Prolytix team was timely, precise, concise, and helpful in developing the best immunoassay for our needs. We successfully improved upon the published finding and also gained certainty about species specificity. It is essential to have good assays to clearly understand biology. I am very grateful to have had the opportunity to work with this team and hope to work with you again in the near future.
Director, Immunology & Biomarkers, midsized biotech company